Liver transplantation is the accepted treatment for end-stage-liver failure and is the last option for the patient.
Andrea Schlegel, Queen Elizabeth Hospital, U.K, who has been involved in the development of Hypothermic Oxygenated Perfusion (HOPE), interacted with liver and kidney transplant surgeons at MIOT International.
Hypothermic Oxygenated Perfusion (HOPE) can make marginal or high-risk donor livers transplantable.
The perfusion machine helps liver to recover from any damage it may have sustained when being removed from the donor.